RedoxTherapies, Juno Therapeutics deal

Juno acquired fellow cancer company RedoxTherapies. RedoxTherapies will receive $10 million in cash up front

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE